Physician profile
Marc Gerdisch
NPI 1508822255
$1,353,902.83
in general payments reported to CMS, 2019-2025
52 companies · $425K in 2025
The $425K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $115K · 2020: $133K · 2021: $107K · 2022: $103K · 2023: $178K · 2024: $293K · 2025: $425K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $709K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $86K · Travel and Lodging: $51K · Honoraria: $22K · Royalty Or License: $16K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $708,786.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $86,340.00 |
| Travel and Lodging | $50,627.08 |
| Honoraria | $22,000.00 |
| Royalty Or License | $15,862.58 |
| Food and Beverage | $12,166.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $459,454.16 | 2019-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Arthrex, INC. | $441,110.23 | 2023-2025 | Shoulder Suture Cerclage Cerclage, Arthrex, Shoulder Suture Fiberwire Cerclage |
| Artivion, INC. | $143,290.15 | 2019-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Clearflow INC. | $120,500.00 | 2022-2025 | Pleuraflow System With Flowglide |
| Biostable Science & Engineering | $110,054.87 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $63,311.37 | 2019-2024 | Walterlorenz Surgical Assist Arm |
| Edwards Lifesciences Corporation | $7,652.08 | 2019-2025 | Inspiris Resilia Aortic Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $3,705.09 | 2021-2025 | Epic, Diamondback Peripheral, Perclose Prostyle |
| Medtronic, INC. | $868.71 | 2021-2025 | Corevalve Evolut R, Situate, Retia Medical |
| Medtronic Vascular, INC. | $377.72 | 2019-2020 | |
| Abiomed | $361.61 | 2019-2025 | Impella |
| Corcym INC | $304.35 | 2024-2025 | Memo 4d, Perceval |
| Boehringer Ingelheim Pharmaceuticals, INC. | $266.64 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $234.01 | 2019-2025 | Lifevest |
| Chiesi USA, INC. | $193.49 | 2019-2023 | Cleviprex, Kengreal |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hemosonics LLC | $181.66 | 2020-2021 | |
| Crossroads Orthopedics, LLC | $175.53 | 2023-2024 | |
| Encore Medical, Lp | $150.00 | 2023 | Djo Surgical |
| Depuy Synthes Sales INC. | $139.97 | 2025 | Matrixrib, Synthecel, Matrixneuro |
| Ethicon US, LLC | $137.03 | 2023-2025 | Vistaseal, Echelon; Endopath |
| La Jolla Pharmaceutical Company | $132.10 | 2025 | Giapreza |
| Bolton Medical INC | $98.47 | 2024 | Treo Abdominal Stent-Graft System |
| Covidien Lp | $78.24 | 2019 | |
| Lemaitre Vascular, INC. | $77.63 | 2019-2023 | Tyke, Patch, Pledget and Intracardiac, Restoreflow |
| Mallinckrodt Enterprises LLC | $72.19 | 2019 | |
| Boston Scientific Corporation | $69.49 | 2020-2025 | Enroute Transcarotid Neuroprotection System |
| Stryker Corporation | $68.36 | 2021-2025 | Na |
| Trevena, INC. | $58.73 | 2021-2022 | |
| Kls-Martin L.P. | $56.36 | 2020-2024 | |
| Vital Connect, INC | $56.30 | 2024 | Vitalpatch Rtm |
| Supreme Orthopedic Systems, LLC | $48.01 | 2025 | |
| Mallinckrodt Hospital Products INC. | $46.12 | 2020 | |
| Angiodynamics, INC. | $45.79 | 2023-2024 | Angiovac |
| Sanara Medtech INC. | $45.63 | 2021-2022 | |
| Kci USA, INC. | $44.77 | 2021-2023 | Prevena Restor Arthroform, Prevena |
| Kestra Medical Technology Services, INC. | $43.97 | 2022-2024 | Assure Wcd |
| Elutia, INC. | $42.06 | 2019-2021 | |
| Davol INC. | $36.29 | 2021-2022 | |
| Baxter Healthcare | $33.60 | 2023 | Preveleak |
| W. L. Gore & Associates, INC. | $33.51 | 2022-2024 | Gore Excluder Iliac Branch Endoprosthesis |
| Quest Medical INC. | $31.49 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $30.00 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $25.37 | 2025 | |
| Cerus Corporation | $24.57 | 2023 | Intercept Blood System For Platelets |
| Karl Storz Endoscopy-America | $22.62 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $20.41 | 2025 | |
| Biomerieux INC | $17.07 | 2023 | Nephrocheck Liquid Control Kit |
| Advanced Respiratory, INC | $16.58 | 2019 | |
| Becton, Dickinson and Company | $16.50 | 2019 | |
| Bard Peripheral Vascular, INC. | $15.45 | 2021 | |
| Imperative Care, INC | $15.03 | 2024 | Prodigy Catheter |
| E.R. Squibb & Sons, L.L.C. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$14,250.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Gerdisch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.